
Q3 2026 Results
Third quarter 2026 results were reviewed by management during a live audio webcast with the financial community on October 30, 2026. The presentation was followed by a Q&A session.
Press Releases
Upcoming Events
17Nov
Jefferies Global Healthcare Conference – London
Speaker: Jean-François Toussaint, Global Head of Research and Development, Vaccines
Conferences
24Nov
Leerink Partners East Coast (POLARxPRESS) Bus Tour 2026 – Boston
Speaker: Manuela Buxo, Executive Vice President, Head of Specialty Care
Conferences
28Jan
Fourth quarter & full year 2026 results
Fourth quarter 2026 results will be reviewed by management during a live audio webcast with the financial community on January 28, 2027. The presentation will be followed by a Q&A session.
13:30 - 14:30 CET (7:30am - 8:30am EST)
Quarterly results



Dividend (in dollars) per ADR (½ share)

Environment, Social, Governance
As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.
Contact Our Investor Relations Team
For general inquiries
Please contact the switchboard, +33 (0)1 53 77 40 00
